News
The nonprofit of former 23andMe CEO and Co-Founder Anne Wojcicki won a bid to acquire the company.
Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron Pharmaceuticals’ offer for the DNA-testing company in a bankruptcy ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results